[1] (2013) Diagnostic and Statistical Manual of Mental Disorders American Psychiatric Association, 5th Edition, American Psychiatric Publishing, Arlington, 189-195.
[2] Patel, G. and Fancher, T.L. (2013) In the Clinic. Generalized Anxiety Disorder. Annals of Internal Medicine, 159, 1-11.
http://dx.doi.org/10.7326/0003-4819-159-11-201312030-01006
[3] Lydiard, R.B. (2003) The Role of GABA in Anxiety Disorders. Journal of Clinical Psychiatry, 64, 21-27.
[4] Dunlop, B.W. and Davis, P.G. (2008) Combination Treatment with Benzodiazepines and SSRIs for Comorbid Anxiety and Depression: A Review. Prim Care Companion. Journal of Clinical Psychiatry, 10, 222-228.
http://dx.doi.org/10.4088/PCC.v10n0307
[5] Fulton, B. and Brogden, R.N. (1997) Buspirone. CNS Drugs, 7, 68-88.
http://dx.doi.org/10.2165/00023210-199707010-00007
[6] Buspirone Monograph. Drugs.com.
[7] Jadhav, S.A., Gaikwad, R.V., Gaonkar, R.K., Thorat, V.M., Gursale, S.C. and Balsara, J.J. (2008) Dose-Dependent Response of Central Dopaminergic Systems to Buspirone in Mice. Indian Journal of Experimental Biology, 46, 704-714.
[8] Cohn, J.B., Rickels, K. and Steege, J.F. (1989) A Pooled, Double-Blind Comparison of the Effects of Buspirone, Diazepam and Placebo in Women with Chronic Anxiety. Current Medical Research and Opinion, 11, 304-320.
http://dx.doi.org/10.1185/03007998909115213
[9] Murphy, S.M., Owen, R. and Tyrer, P. (1989) Comparative Assessment of Efficacy and Withdrawal Symptoms after 6 and 12 Weeks’ Treatment with Diazepam or Buspirone. The British Journal of Psychiatry: The Journal of Mental Science, 154, 529-534.
[10] Ryan, M.F. (1991) The Role of Magnesium in Clinical Biochemistry: An Overview. Annals of Clinical Biochemistry, 28, 19-26. http://dx.doi.org/10.1177/000456329102800103
[11] Cardoso, C.C., Lobato, K.R., Binfaré, R.W., Ferreira, P.K., Rosa, A.O., Santos, A.R.S. and Rodrigues, A.L.S. (2009) Evidence for the Involvement of the Monoaminergic System in the Antidepressant-Like Effect of Magnesium. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 33, 235-242.
http://dx.doi.org/10.1016/j.pnpbp.2008.11.007
[12] Poleszak, E., Szewczyk, B., Kêdzierska, E., Wlaz, P., Pilc, A. and Nowak, G. (2004) Antidepressant- and Anxiolytic-Like Activity of Magnesium in Mice. Pharmacology Biochemistry and Behavior, 78, 7-12.
http://dx.doi.org/10.1016/j.pbb.2004.01.006
[13] Poleszak, E., Wlaz, P., Kêdzierska, E., Nieoczym, D., Wyska, E., Szymura-Oleksiak, J., Fidecka, S., et al. (2006) Immobility Stress Induces Depression-Like Behavior in the Forced Swim Test in Mice: Effect of Magnesium and Imipramine. Pharmacological Research, 58, 746-752.
[14] Hiremath, Sh.B., Anand, S., Srinivas, L.D. and Rashed, M.R. (2010) Effect of Calcium on Anxiolytic Activity of Diazepam and Verapamil in Rats. Indian Journal of Pharmacology, 42, 406-408.
http://dx.doi.org/10.4103/0253-7613.71889
[15] Joshi, M., Akhtar, M., Najmi, A.K., Khuroo, A.H. and Goswami, D. (2012) Effect of Zinc in Animal Models of Anxiety, Depression and Psychosis. Human & Experimental Toxicology, 31, 1237-1243.
http://dx.doi.org/10.1177/0960327112444938
[16] Poleszak, E., Wlaz, P., Kêdzierska, E., Nieoczym, D., Wróbel, A., Fidecka, S. and Pilc, A. (2007) Nowak G: NMDA/ Glutamate Mechanism of Antidepressant-Like Action of Magnesium in Forced Swim Test in Mice. Pharmacology Biochemistry and Behavior, 88, 158-164.
http://dx.doi.org/10.1016/j.pbb.2007.07.018
[17] Poleszak, E., Wlaz, P., Wróbel, A., Dybala, M., Sowa, M., Fidecka, S., Pilc, A. and Nowak, G. (2007) Activation of the NMDA/Glutamate Receptor Complex Antagonizes the NMDA Antagonist-Induced Antidepressant-Like Effects in the Forced Swim Test. Pharmacological Research, 59, 595-600.
[18] Lister, R.G. (1987) The Use of a Plus-Maze to Measure Anxiety in the Mouse. Psychopharmacology, 92, 180-185.
http://dx.doi.org/10.1007/BF00177912
[19] Dunn, R.W., Corbett, R. and Fielding, S. (1989) Effects of 5-HTlA Receptor Agonist and NMDA Receptor Antagonist in the Social Interaction Test and the Elevated plus Maze. European Journal of Pharmacology, 169, 1-10.
http://dx.doi.org/10.1016/0014-2999(89)90811-X
[20] Poleszak, E. (2008) Benzodiazepine/GABAA Receptors Are Involved in Magnesium-Induced Anxiolytic-Like Behavior in Mice. Pharmacological Reports, 60, 483-489.